Fig. 1

Formononetin protects against experimental AP in mice. A Structure of Formononetin. B Schedule of experimental AP establishment. C, D HE staining of the pancreas (C) and histologic score (D); scale bar, 50 μm. E Detection of pancreatic edema. F Detection of serum amylase level. G Detection of serum lipase levels. H Detection of pancreatic MPO level. I-L qRT-PCR for pancreatic mRNA quantitative analysis of tnf-α (I), mcp-1(J), il-6 (K) and il-1β (L). Octreotide was used as a positive drug. FMN Formononetin. Data were expressed as mean ± SD, n = 5–8 in each group. * p < 0.05, ** p < 0.01, *** p < 0.001